Cargando…

Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease

BACKGROUND & AIMS: The new name and diagnostic criteria of metabolic-associated fatty liver disease (MAFLD) was proposed in 2020. Although chronic HBV infection has protective effects on lipid profiles and hepatic steatosis, the impact of chronic HBV infection on clinical outcomes of MAFLD requi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yu-Ming, Hsieh, Tsung-Han, Wang, Chia-Chi, Kao, Jia-Horng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432217/ https://www.ncbi.nlm.nih.gov/pubmed/37600956 http://dx.doi.org/10.1016/j.jhepr.2023.100836

Ejemplares similares

Erratum to ‘Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease’ (JHEP Reports 5 [2023] 100836)
por: Cheng, Yu-Ming, et al.
Publicado: (2023)

Risk stratification of HBV infection in Asia-Pacific region
por: Kao, Jia-Horng
Publicado: (2014)

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
por: Huang, Shang-Chin, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023)

Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
por: Huang, Jee-Fu, et al.
Publicado: (2023)

Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
por: Lee, Jung Il
Publicado: (2022)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
por: Lin, Huapeng, et al.
Publicado: (2021)

Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
por: Xiao, Yuji, et al.
Publicado: (2023)

Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
por: Dai, Yi-Ning, et al.
Publicado: (2023)

Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
por: Tang, Si-Ying, et al.
Publicado: (2023)

Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Hwang, Tae-In, et al.
Publicado: (2021)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
por: Yeh, Ming-Lun, et al.
Publicado: (2023)

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms
por: He, Yuan, et al.
Publicado: (2022)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

CT-based methods for assessment of metabolic dysfunction associated with fatty liver disease
por: Hu, Na, et al.
Publicado: (2023)

Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
por: Virk, Ghazala S, et al.
Publicado: (2023)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
por: Song, Byeong Geun, et al.
Publicado: (2023)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)

Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Therapeutic developments in metabolic dysfunction-associated fatty liver disease
por: Shi, Yiwen, et al.
Publicado: (2022)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
por: Yu, Cheng-Wei, et al.
Publicado: (2023)

The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
por: Martín-Mateos, Rosa, et al.
Publicado: (2021)

HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases
por: Cheng, Zhimeng, et al.
Publicado: (2021)

Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus
por: Miyake, Teruki, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
por: Ng, Cheng Han, et al.
Publicado: (2022)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
por: Cheng, Yuan-Lung, et al.
Publicado: (2017)

Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease
por: Machado, Mariana Verdelho
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01qba6t8ik3nvs2u8bhok0he8d